Shopping Cart

LAFEROBION® drops 5 ml antiviral, antiproliferative and immunomodulating effect

LAFEROBION® drops 5 ml  antiviral, antiproliferative and immunomodulating effect
Product Code :924
Availability :In Stock
  • $25.00

Free Shipping

Shipping time 12-14 days.

Ask a question

Laferobion - suppositories drops 5 ml

  • Indication-
  • -in the complex therapy of acute respiratory viral infections (ARVIs)

  •  -seasonal epidemics

  • Pharmacological properties
  • Recombinant interferon alpha-2b is a highly purified water-soluble protein with a molecular weight of 19,300 da.

  • It has antiproliferative effect on tumor cells, and also has antiviral and immunomodulating effects. The action of interferon alpha-2b is manifested by binding to specific receptors on the cell surface membrane and initiating a complex of sequential intracellular reactions associated with the induction of a number of enzymes and the implementation of cellular functions, namely: suppressing virus replication in an infected cell and reducing tumor cell proliferation; with the implementation of immunomodulatory processes (increased phagocytic activity of macrophages, increased specific cytotoxicity of lymphocytes to target cells).

  • Indications
  • The drug is used in complex therapy in adults and children with:

  • acute and chronic viral hepatitis B (moderate and severe forms);
  • chronic hepatitis C;
  • acute and chronic septic diseases of a viral nature;
  • acute viral, bacterial and mixed infections, including in newborns;
  • acute and chronic septic diseases of viral and bacterial etiology, including the diminished forms of acute and chronic sepsis;
  • herpes infections of various localization (herpes zoster, multiple skin herpetic eruptions, genital herpes, herpetic keratoconjunctivitis and keratouveitis);
  • laryngeal papillomatosis;
  • multiple sclerosis;
  • malignant melanoma, uveal melanoma, renal cell carcinoma, superficially localized bladder cancer, ovarian and breast cancer, Kaposi’s sarcoma due to HIV infection, chronic myelogenous leukemia, hairy cell leukemia, non-Hodgkin’s lymphoma, basal cell carcinoma, lymphoma cell carcinoma, mycosis).
  • Application
  • The drug is used in the form of a solution. Laferobion solution is administered intravenously (drip), intramuscularly, subcutaneous, intradermally, intraperitoneally, intravesical, rectal, intranasal, subconjunctival.

  • Laferobion 100,000 IU for Intranasal Use

  • SARS in children, including newborns

  • Intranasally, 4–6 drops in each nasal passage 3–6 times a day for 3–5 days; the dosage of the drug for newborns is 20,000-50,000 IU / ml, for other children - 100,000 IU / ml. It is permissible to introduce into the nasal passages (alternately) cotton turundas moistened with Laferobion solution for 10-15 minutes.

  • SARS in adults

  • Intranasally 0.25 ml of Laferobion solution (100,000 ME / ml) in each nasal passage 6-8 times a day. Before use, the administered Laferobion solution should be heated in a syringe (use a syringe without a needle) to body temperature, the remainder of the solution should be stored in the refrigerator, protecting from bacterial contamination.

Write a review

Note: HTML is not translated!
    Bad           Good